Fouad Namouni
2020
In 2020, Fouad Namouni earned a total compensation of $6.7M as President, Research and Development at Blueprint Medicines.
Compensation breakdown
| Non-Equity Incentive Plan | $103,114 |
|---|---|
| Option Awards | $3,326,739 |
| Salary | $186,154 |
| Stock Awards | $3,052,725 |
| Total | $6,668,732 |
Namouni received $3.3M in option awards, accounting for 50% of the total pay in 2020.
Namouni also received $103.1K in non-equity incentive plan, $186.2K in salary and $3.1M in stock awards.
Rankings
In 2020, Fouad Namouni's compensation ranked 1,501st out of 13,090 executives tracked by ExecPay. In other words, Namouni earned more than 88.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,501 out of 13,090 | 89th |
Division Manufacturing | 563 out of 5,621 | 90th |
Major group Chemicals And Allied Products | 204 out of 2,254 | 91st |
Industry group Drugs | 170 out of 1,954 | 91st |
Industry Pharmaceutical Preparations | 118 out of 1,459 | 92nd |
Pay ratio
| Fouad Namouni's Pay | $6,668,732 |
|---|---|
| Median Employee's Pay | $332,124 |
| Pay Ratio | 20to 1 |
In 2020, the annual total compensation of Fouad Namouni was $6,668,732.
The annual total compensation of the median employee at Blueprint Medicines was $332,124.
The ratio of Fouad Namouni's pay to the pay of median employee was therefore 20 to one.
Source: SEC filing on April 21, 2021.
Namouni's colleagues
We found four more compensation records of executives who worked with Fouad Namouni at Blueprint Medicines in 2020.